Sorafenib is an oral, small-molecule, multi-targeted tyrosine kinase inhibitor (TKI) and the first systemic agent shown to improve survival in advanced hepatocellular carcinoma (HCC).
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea